Sriram Bandi Creates Early Stage Liver Cells from Stem Cells

Sriram Bandi, PhD, a NYSCF – Druckenmiller Fellowship alumnus, published work in the February 2012 Journal of Cell Science finding that cells derived from a human embryonic stem cell (hESC) line mimicked the characteristics of early stage liver cells and could potentially be used to help support liver function and metabolism in patients suffering from liver disease. The research of Dr. Bandi and his team suggests that by studying the origin and function of hESC-derived stem cells during the derivation process, scientists may be able to pinpoint suitable clinical applications across a range of diseases. Dr. Bandi completed his fellowship at Albert Einstein College of Medicine, where he is now a Research Associate at the Marion Besser Liver Research Center.